Nyumbani › Myeloma Nyingi Inayowaka Polepole › Michigan
Majaribio ya kliniki ya Myeloma Nyingi Inayowaka Polepole katika jimbo la Michigan
Masomo 4 ya Myeloma Nyingi Inayowaka Polepole yanatafuta washiriki katika vituo vya jimbo la Michigan.
Maandishi rasmi ya utafiti (Kiingereza)
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
- Barbara Ann Karmanos Cancer Institute - Detroit, Detroit
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT07393282Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
- MyMichigan Medical Center Gratiot, Alma
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- na zaidi ya 42
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 19 Ago 2026 · NCT03937635A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
- University of Michigan Health, Ann Arbor
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 8 Jul 2026 · NCT06140524Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
- West Michigan Cancer Center, Kalamazoo
InaajiriUtafiti wa uchunguzi
Umri 18 na zaidi · Jinsia zote · Imesasishwa 7 Mei 2026 · NCT02269592Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.